Version history
Lipid Manager
30
ASO score
Text
11/100
Reviews
50/100
Graphic
60/100
Other
0/100
App Rating
4.3
Votes
4
App Age
8y 10m
Last Update
Sep 16, 2025
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Rating
|
4.33
|
4.6
|
-6%
|
|
Number of Ratings (Voted)
|
4
|
65.3K
|
-100%
|
|
App Age
|
8y 9m
|
9y 2m
|
-4%
|
|
In-app Purchases Price
|
$0
|
$30
|
|
|
Update Frequency
|
88d
|
127d
|
-31%
|
|
Title Length
|
13
|
25
|
-48%
|
|
Subtitle Length
|
0
|
26
|
|
|
Description Length
|
1 052
|
2 647
|
-60%
|
|
Number of Screenshots
|
1443
|
1385
|
+4
%
|
|
Size
|
59MB
|
244MB
|
-76
%
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 06, 2025 | Dec 13, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 06, 2025 | Dec 13, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 06, 2025 | Dec 13, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 06, 2025 | Dec 13, 2025 |
|---|---|---|
|
No results were found!
|
||
Ranking Keywords in United States
| Keywords | App Rank |
|---|
Analyze this and other apps using Asolytics tools
Text ASO
Title
(
Characters:
13
of 30
)
Lipid Manager
Subtitle
(
Characters:
0
of 30
)
Description
(
Characters:
1052
of 4000
)
The ACC Lipid Manager app (formerly LDL-C Manager) provides 4-tools-in-1 to help clinicians manage a patient’s triglycerides and LDL-C from therapy initiation through treatment calibration with the goal of lowering ASCVD risk:
-ASCVD Risk Estimator: Calculate pretreatment ASCVD risk and determine the appropriateness of statin therapy for the patient
-LDL-C Lowering Therapy tool: Assess response to a statin, and determine if other therapies should be considered and in what order
-Statin Intolerance tool: Evaluate the patient for possible statin intolerance, and determine appropriate next steps
-Hypertriglyceridemia tool: Use the app to see tailored consensus recommendations for both lifestyle intervention and pharmacological management of high-risk patients with persistent hypertriglyceridemia
The information and recommendations in this App are not meant to represent the only or best course of care nor replace clinical judgement. Therapeutic options should be determined after discussion between the patient and their care provider.
}
Read more
Other
